What are the current challenges in the medtech industry and how do you see it changing in the next 5 years?
Switzerland has a high concentration of medtech companies and medtech know-how. Yet, realizing strategic business models for technologies that lie at the intersection of medtech and digital health is still considered challenging. It is so complex and brings together numerous stakeholders. A lot of investment is required before a product can be brought to market. Moreover, extensive regulatory obligations and increasing quality requirements further prolong the process of market approval. In the upcoming years, the approaching change in the MDR and IVDR will place financial burdens on the industry. Startups will be hugely impacted by this change, as more time, efforts, and expenses will be needed for product documentation and subsequent approval.
What are you most proud of achieving with Rea?
I feel lucky and proud to have the chance to lead my company towards developing a technology that would make a difference in the lives of millions of pregnant women and their babies. I am proud to raise awareness about the shortcomings in technologies developed for women and the lack of global efforts put into that domain; highlighting the existing gap between today’s current hot topics in diagnostics and the actual needs of women.
What are your plans for the future, and where do you see Rea in another 3-4 years?
My biggest goal for the moment is to find the right people to expand my team and to bring Rea’s technical and clinical development forward. In 3-4 years from today, I see Rea’s product in the hands of the women who would benefit from it, hopefully making a difference in the rates of preterm birth around the world.
Was there any piece of advice you received during your involvement with the W.A. de Vigier Foundation that stuck with you? Or a certain meaningful anecdote that you could share about this time?
I am thankful to all members and organizers of the W.A. de Vigier Foundation who ensured a safe and smooth experience for all candidates given the challenges surrounding the COVID-19 pandemic. My journey was stimulating and inspiring at the same time. Not only did I have to prove my business idea but also my leadership abilities, management skills and entrepreneurial character. In the end, I learned quite interesting things about myself and I am grateful for those insights.